How should tinea versicolor presenting as hypo‑ or hyperpigmented macules on the trunk of a young adult be diagnosed and treated?

Diagnosis and Treatment of Tinea Versicolor

Diagnosis

The diagnosis of tinea versicolor is primarily clinical, based on the characteristic appearance of scaly hypo- or hyperpigmented macules on the trunk, and can be confirmed with potassium hydroxide (KOH) preparation if needed. 1, 2

Clinical Recognition

• Look for scaly macules or patches that are either hypopigmented, hyperpigmented, or a combination of both, predominantly on the upper trunk, neck, and upper arms 1, 3, 2
• In dark-skinned individuals, hypopigmented lesions are the most common presentation 3
• The lesions are typically asymptomatic, though mild pruritus may occur 1

Confirmatory Testing (When Needed)

• KOH preparation reveals the pathognomonic "spaghetti and meatballs" appearance: short, stubby hyphae intermixed with clusters of yeast spores 1, 2
• Dermoscopy shows nonuniform perifollicular hypopigmentation with clearly demarcated borders and patchy scaling 4
• Wood's lamp examination may show yellow-gold fluorescence, though this is not always present 2

Key Differential Diagnoses to Exclude

• Vitiligo (lacks scaling, complete depigmentation) 3
• Pityriasis alba (primarily in children, less distinct borders) 3
• Seborrheic dermatitis (more erythema, different distribution) 3
• Pityriasis rosea (herald patch, Christmas tree pattern) 3

---

Treatment Approach

Topical antifungal therapy is the first-line treatment for tinea versicolor due to superior safety profile, fewer drug interactions, and lower cost compared to systemic therapy. 1

First-Line: Topical Antifungal Agents

Non-Specific Topical Options

• Selenium sulfide 2.5% shampoo: Apply to affected areas, leave on for 10 minutes, then rinse; use daily for 1-2 weeks 2, 5
• Zinc pyrithione shampoo: Similar application as selenium sulfide 2, 5
• Ketoconazole shampoo: Apply and leave on briefly before rinsing 5

Specific Topical Antifungals

• Imidazoles (clotrimazole, miconazole): Apply twice daily for 2-4 weeks 2
• Allylamines (terbinafine): Apply once or twice daily 2
• Ciclopirox olamine: Alternative topical option 2, 5

Second-Line: Oral Antifungal Therapy

Reserve systemic therapy for extensive disease, frequent recurrences, or failure of topical treatment. 1

Indications for Oral Therapy

• Widespread involvement covering large body surface area 1
• Disease refractory to adequate topical therapy 1
• Frequent recurrences despite prophylaxis 1
• Patient preference when compliance with topical therapy is poor 1

Oral Treatment Options

• Fluconazole: Short-term treatment is effective and well-tolerated 5
• Itraconazole: Effective alternative for difficult cases 5

Note: While oral therapy offers advantages including better compliance, shorter treatment duration, and reduced recurrence rates, it carries higher cost, more adverse events, and potential drug interactions 1

---

Prevention of Recurrence

Long-term intermittent prophylactic therapy should be considered for patients with frequent recurrence, particularly during warm and humid periods. 1, 2

Prophylactic Strategies

• Use topical antifungal agents intermittently (e.g., selenium sulfide or ketoconazole shampoo once weekly or monthly) during high-risk periods 2, 5
• Educate patients that recurrence is common due to the commensal nature of Malassezia species 2
• Emphasize good personal hygiene practices 2

Important Patient Counseling Points

• Pigmentary changes may persist for months after successful mycological cure, as repigmentation requires time for melanocyte recovery 1, 3
• The condition is not contagious despite being a fungal infection 1
• Predisposing factors include heat, humidity, hyperhidrosis, and oily skin 5

---

Common Pitfalls to Avoid

• Do not mistake persistent hypopigmentation for treatment failure—the fungus may be eradicated while pigmentary changes lag behind 1, 3
• Do not use oral antifungals as first-line therapy unless there are specific indications, as topical therapy is safer and more cost-effective 1
• Do not forget to address recurrence prevention, as this is a chronic-relapsing condition without prophylaxis 1, 2, 5
• In dark-skinned patients, histopathology may show thicker stratum corneum and more sequestered melanosomes, which can delay repigmentation 3